We are a charity and rely on donations
Charity Number: 1117194 (England and Wales)
Registered Company: 06000961
Registered address:
Shift.ms, Platform, New Station Street, LS1 4JB, United Kingdom
London office:
Shift.ms, Somerset House, Strand, West Goods Entrance, London WC2R 1LA, United Kingdom
©2024 Shift.ms
Thanks for sharing @Stumbler
Yes, encouraging news with a negative twist, given that Bexarotene now won't be progressed to Stage 3 trials. However, it is now beyond doubt that remyelination is possible which is a huge step forward. Let's keep watching and waiting @stumbler....